Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference

Pigment Cell and Melanoma Research - Tập 25 Số 3 - 2012
Khaled Ezzedine1,2,3, Henry W. Lim4, Tamio Suzuki5, Ichiro Katayama6, Iltefat Hamzavi4, C. Lan7, Boon Kee Goh8, Tag S. Anbar9, Carla Castro10, Azalea Lee11, Davinder Parsad12, Nanja van Geel13, I. Caroline Le Poole14, Naoki Oiso15, Laïla Benzekri16, Richard A. Spritz17, Yvon Gauthier1,2,3, Seung Kyung Hann18, Mauro Picardo19, Alain Taı̈eb1,2,3
1Department of Dermatology and Pediatric Dermatology
2National Centre for Rare Skin Disorders, Hôpital Pellegrin, Bordeaux, France
3University of Bordeaux, Biothérapie des maladies géniques et cancers, U1035, Bordeaux, France
4Department of Dermatology, Henry Ford Hospital, Detroit, Mi USA
5Department of Dermatology, Yamagata University School of Medicine, Yamagata, Japan
6Department of Dermatology, Graduate School of Medicine, Osaka University, Osaka, Japan
7Department of Dermatology, Kaohsiung Medical University, Kaohsiung City, Taiwan
8National Skin Centre, Singapore, Singapore
9Department of Dermatology, Al-Minya University, Al-Minya, Egypt
10Department of Dermatology, Santa Casa de Misericórdia Hospital, Pontifical and Catholic University of Paraná, Curitiba, Parana, Brazil
11Department of Dermatology, Dongguk University Ilsan Hospital, Gyeonggi-do, South Korea
12Department of Dermatology, PGIMER, Chandigarh, India
13Department of Dermatology, Ghent University Hospital, Ghent, Belgium
14Departments of Pathology, Microbiology and Immunology, Oncology Institute, Loyola University Chicago, Chicago, IL, USA
15Department of Dermatology, Kinki University School of Medicine, Osaka, Japan
16Department of Dermatology, Ibn Sina University Hospital, Rabat, Morocco and Mohammed V Souissi University, Rabat, Morocco
17Human Medical Genetics Program and Department of Pediatrics, University of Colorado Denver School of Medicine, Aurora, CO, USA
18Korea Institute of Vitiligo Research, Drs. Woo & Hann’s Skin Center, Seoul, South Korea
19San Gallicano Dermatologic Institute, Via Elio Chianesi, Roma, Italy

Tóm tắt

Summary

During the 2011 International Pigment Cell Conference (IPCC), the Vitiligo European Taskforce (VETF) convened a consensus conference on issues of global importance for vitiligo clinical research. As suggested by an international panel of experts, the conference focused on four topics: classification and nomenclature; definition of stable disease; definition of Koebner’s phenomenon (KP); and ‘autoimmune vitiligo’. These topics were discussed in seven working groups representing different geographical regions. A consensus emerged that segmental vitiligo be classified separately from all other forms of vitiligo and that the term ‘vitiligo’ be used as an umbrella term for all non‐segmental forms of vitiligo, including ‘mixed vitiligo’ in which segmental and non‐segmental vitiligo are combined and which is considered a subgroup of vitiligo. Further, the conference recommends that disease stability be best assessed based on the stability of individual lesions rather than the overall stability of the disease as the latter is difficult to define precisely and reliably. The conference also endorsed the classification of KP for vitiligo as proposed by the VETF (history based, clinical observation based, or experimentally induced). Lastly, the conference agreed that ‘autoimmune vitiligo’ should not be used as a separate classification as published evidence indicates that the pathophysiology of all forms of vitiligo likely involves autoimmune or inflammatory mechanisms.

Từ khóa


Tài liệu tham khảo

10.1111/j.1365-4632.2008.03672.x

10.1016/0190-9622(95)91282-7

Boissy R.E., 2010, Vitiligo, 175

10.1111/j.1600-0749.2004.00130.x

Boissy R.E., 1995, Cutaneous Medicine and Surgery: An Integrated Program in Dermatology, 1210

10.1111/j.1600-0749.2007.00396.x

10.1111/1523-1747.ep12476636

10.1016/1046-199X(95)90112-4

10.1007/BF00455391

El‐Nasr H.S., 1963, Koebner’s phenomenon in dermatology. A study and report of some unusual stigmata of this phenomenon, J. Egypt Med. Assoc., 46, 1067

10.1111/j.1365-2133.2011.10311.x

10.1111/j.1365-2133.2011.10709.x

10.1016/j.jaad.2010.08.031

10.1111/j.1524-4725.2005.31203

10.1016/S0190-9622(88)70071-7

10.1016/0190-9622(95)90131-0

Gauthier Y., 1995, The importance of Koebner’s phenomenon in the induction of vitiligo vulgaris lesions, Eur. J. Dermatol., 5, 704

Gauthier Y., 2010, Vitiligo, 167

10.1034/j.1600-0749.2003.00070.x

10.1111/j.1365-2133.2008.08881.x

10.1111/j.1755-148X.2010.00703.x

10.1111/j.1468-3083.2010.03847.x

10.1111/j.1755-148X.2011.00838.x

10.1111/j.1755-148X.2011.00922.x

Gopinathan T., 1965, A study of the lesion of vitiligo, Arch. Dermatol., 91, 397, 10.1001/archderm.1965.01600100113028

10.1084/jem.20101102

10.1001/archderm.140.6.677

10.1016/S0190-9622(96)90718-5

Hann S.K., 2000, Vitiligo, 81, 10.1002/9780470760116

10.1111/j.1346-8138.1992.tb03211.x

10.1046/j.1365-4362.1997.00162.x

10.1016/S0738-081X(97)00130-2

10.3349/ymj.2000.41.2.209

10.1007/s001050051309

10.1016/j.jaad.2007.06.039

10.1111/j.1365-2133.2010.10202.x

Koebner H., 1876, Zur aetiologie der psoriasis, Vrtljscher Dermatol. Syphil., 8, 559

10.1111/j.1365-2133.1988.tb01778.x

10.1111/j.1365-2133.2009.09077.x

10.1159/000077336

Lahiri K., 2004, Inducing repigmentation by regrafting and phototherapy (311 nm) in punch grafting failure cases of lip vitiligo: a pilot study, Indian J. Dermatol. Venereol. Leprol., 70, 156

10.1016/S0738-081X(97)00127-2

10.1159/000131485

10.1111/j.1600-0625.1993.tb00023.x

10.1016/0002-9343(71)90232-4

10.1159/000018449

10.4103/0378-6323.69097

10.1111/j.1365-4362.1982.tb02070.x

10.1111/1523-1747.ep12500086

10.2310/7750.2006.00018

10.1001/archderm.135.4.407

Ormsby O.S., 1948, Koebner’s Phenomenon in Dermatology: A Study and Report of Some Unusual Stigmata of this Phenomenon

10.1007/978-1-4615-9272-3

Ortonne J.P., 2000, Vitiligo, 76, 10.1002/9780470760116.ch10

Parsad D., 2008, Standard guidelines of care for vitiligo surgery, Indian J. Dermatol. Venereol. Leprol., 74, S37

Passeron T., 2010, Vitiligo, 35, 10.1007/978-3-540-69361-1_4

10.1159/000247164

10.1007/s00403-007-0748-7

10.1111/j.1365-4632.2008.03660.x

10.1097/00000372-200404000-00004

10.1038/jid.2011.321

10.1111/j.1365-2133.1978.tb01988.x

10.1007/978-3-540-69361-1_2

10.1111/j.1600-0749.2006.00355.x

10.1056/NEJMcp0804388

10.1111/j.1755-148X.2008.00511.x

10.1111/j.1600-0560.1984.tb00361.x

10.1371/journal.pone.0018907

10.1111/j.1468-3083.2010.03808.x

Whitton M.E., 2010, Interventions for vitiligo, Cochrane Database Syst. Rev., CD003263

10.1038/labinvest.3780138

Yagi H., 1997, Vitiligo with raised inflammatory borders: involvement of T cell immunity and keratinocytes expressing MHC class II and ICAM‐1 molecules, Eur. J. Dermatol., 7, 19

Thông tin
Thông tin xuất bản

Pigment Cell and Melanoma Research

Tập 25 Số 3

Thông tin tác giả